Unlocking the potential of HK2 in cancer metabolism and therapeutics

SN Garcia, RC Guedes… - Current medicinal …, 2019 - ingentaconnect.com
Glycolysis is a tightly regulated process in which several enzymes, such as Hexokinases
(HKs), play crucial roles. Cancer cells are characterized by specific expression levels of …

State of the art in African trypanosome drug discovery

R T. Jacobs, B Nare, M A. Phillips - Current topics in medicinal …, 2011 - benthamdirect.com
African sleeping sickness is endemic in sub-Saharan Africa where the WHO estimates that
60 million people are at risk for the disease. Human African trypanosomiasis (HAT) is 100 …

Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy

LR Tian, MZ Lin, HH Zhong, YJ Cai, B Li, ZC Xiao… - Biomaterials …, 2022 - pubs.rsc.org
A majority of cancers fail to respond to immunotherapy due to the immunosuppressive tumor
microenvironment (TME), and metabolic regulation of the TME has been a promising …

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance

A Goldman, S Khiste, E Freinkman, A Dhawan… - Science …, 2019 - science.org
Metastable phenotypic state transitions in cancer cells can lead to the development of
transient adaptive resistance or tolerance to chemotherapy. Here, we report that the …

Kinases as druggable targets in trypanosomatid protozoan parasites

C Merritt, LE Silva, AL Tanner, K Stuart… - Chemical …, 2014 - ACS Publications
1.1. Kinetoplastid Parasites as Pathogenic Parasites: Overview, Life Cycle, Relevance of
Life Stages to Health Over the past decade, neglected tropical diseases (NTDs) have seen a …

A Target-Based High Throughput Screen Yields Trypanosoma brucei Hexokinase Small Molecule Inhibitors with Antiparasitic Activity

ER Sharlow, TA Lyda, HC Dodson… - PLoS neglected …, 2010 - journals.plos.org
Background The parasitic protozoan Trypanosoma brucei utilizes glycolysis exclusively for
ATP production during infection of the mammalian host. The first step in this metabolic …

Glycosomal targets for anti-trypanosomatid drug discovery

X Barros-Alvarez, M Gualdron-Lopez… - Current medicinal …, 2014 - ingentaconnect.com
Glycosomes are peroxisome-related organelles found in all kinetoplastid protists, including
the human pathogenic species of the family Trypanosomatidae: Trypanosoma brucei …

Discovery and genetic validation of chemotherapeutic targets for Chagas' disease

JF Osorio-Méndez, AM Cevallos - Frontiers in cellular and infection …, 2019 - frontiersin.org
There is an urgent need to develop new treatments for Chagas' disease. To identify drug
targets, it is important to understand the basic biology of Trypanosoma cruzi, in particular …

Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei

AJ Cáceres, PAM Michels, V Hannaert - Molecular and biochemical …, 2010 - Elsevier
Aldolase (ALD) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of
Trypanosoma brucei are considered to be promising targets for chemotherapeutic treatment …

Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets …

PVSZ Capriles, ACR Guimarães, TD Otto, AB Miranda… - BMC genomics, 2010 - Springer
Background Trypanosoma cruzi is the etiological agent of Chagas' disease, an endemic
infection that causes thousands of deaths every year in Latin America. Therapeutic options …